Atlas Trials

Abrocitinib Expanded Access Protocol in Adolescents and Adults With Moderate to Severe Atopic Dermatitis

Clinical trial NCT04564755 · NO_LONGER_AVAILABLE

Trial details

NCT number
NCT04564755
Sponsor
Pfizer
Status
NO_LONGER_AVAILABLE
Study type
EXPANDED_ACCESS
Atopic Dermatitis

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.